NDT Advance Access originally published online on February 2, 2006
Nephrology Dialysis Transplantation 2006 21(4):889-897; doi:10.1093/ndt/gfi254
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author [2006]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Original Articles: Experimental Nephrology
Vitamin D decreases NF
B activity by increasing IB
levels
1 Department of Clinical Biochemistry and 2 Department of Nephrology, Soroka University Medical Center and Faculty of Health Sciences, Ben-Gurion University, PO Box 151, Beer-Sheva, 84101, Israel
Correspondence and offprint requests to: Amos Douvdevani, PhD, Nephrology Laboratory, Soroka University Medical Center, PO Box 151, Beer-Sheva 84101, Israel. Email: amosd{at}bgu.ac.il
 |
Abstract |
|---|
 Top Abstract IntroductionSubjects and methodsDiscussionReferences |
|---|
Background. In a previous study we demonstrated the inhibitory effect of 1,25-dihydroxyvitamin D (1,25(OH)2D3) and its less calcaemic analog 1,24(OH)2D2 on the production of tumour necrosis factor alpha (TNF
) by human peritoneal macrophages. The aim of the present study is to examine whether this vitamin D inhibition of TNF is mediated by its major transcription factor, nuclear factor-
B (NFB).
Methods. Murine macrophage cells (P388D1) were incubated with 10–7 M 1,25(OH)2D3 or 1,24(OH)2D2 and then stimulated with lipopolysaccharide. NFB activity was assayed using a reporter gene and by electrophoretic mobility shift assay (EMSA). In addition, we evaluated mRNA and protein levels of NFB-p65 and of IB, a potent NFB inhibitor, and phosphorylated IB.
Results. Both 1,25(OH)2D3 and 1,24(OH)2D2 induced a 60% reduction of TNF secretion. By using a reporter gene and EMSA we found that vitamin D markedly reduced NFB activity. 1,25(OH)2D3 or 1,24(OH)2D2 decreased NFB-p65 levels in the nucleus and increased NFB-p65 levels in the cytosol; no changes were observed in the total levels of NFB-p65 protein and mRNA. Concurrently, vitamin D induced a significant increase in mRNA and protein levels of IB (
6.5- and 4.5-fold, respectively). Elevated levels of IB can be explained by the vitamin D-induced prolongation of IB-mRNA half-life from 110 to 190 min and by the decrease in IB phosphorylation.
Conclusions. Vitamin D up-regulates IB levels by increasing mRNA stability and decreasing IB phosphorylation. The increase in IB levels reduces nuclear translocation of NFB and thereby downgrades its activity. Since NFB is a major transcription factor of inflammatory mediators, these findings suggest that the less-calcaemic analog, 1,24(OH)2D2 may be effective as an anti-inflammatory therapeutic agent.
Keywords: IB; macrophages; NFB; tumour necrosis factor alpha; vitamin D
|
Introduction |
|---|
|
TopAbstractIntroductionSubjects and methodsDiscussionReferences |
|---|
The active metabolite of vitamin D, 1,25-dihydroxyvitamin D (1,25(OH)2D3) can be produced not only by the kidney, but also by macrophages, including peritoneal macrophages, especially during inflammation [1]. Furthermore, it has been well established that the physiological role of 1,25(OH)2D3 is not limited to mineral and skeletal homeostasis, but that it also plays a role as an important immune response regulator at inflammatory sites [2]. In a previous study we demonstrated a dose-dependent inhibitory effect of 1,25(OH)2D3 and its less calcaemic analog 1,24(OH)2D2 on both tumour necrosis factor alpha (TNF
) mRNA and protein levels in lipopolysaccharide (LPS)-stimulated human peritoneal macrophages obtained from effluent dialysates of patients in end-stage renal disease undergoing continuous ambulatory peritoneal dialysis and by the murine macrophage cell line P388D1 [3,4]. TNF is a major mediator of host response to pathogens, in that it initiates a powerful proinflammatory cascade which promotes massive recruitment of leukocytes at the infected site. However, excessive production of TNF and protracted or over-activated inflammation are the hallmarks of systemic inflammatory response syndrome as well as inflammatory diseases such as Crohn's disease and rheumatoid arthritis. Therefore, regulation of TNF production may have significant clinical importance [5,6].
The promoter region of the TNF gene contains a complex array of potential regulatory elements. However, the role of these regulatory elements in transcriptional activation of the TNF gene in human monocytes and macrophages remains unclear [7]. Transcriptional activation of the TNF gene in macrophages has been demonstrated to be predominantly dependent on the transcription factor nuclear factor-B (NFB), which has four binding sites in the TNF promoter [6,8].
NFB is a major regulator of gene transcription involved in immune, inflammatory and stress responses. It consists of five proteins which tend to dimerize and are thus kept in the cytoplasm through interaction with IB inhibitory proteins. The most dominant protein in the NFB family is the p65 protein and the best-characterized interaction is that of the transcriptionally active p65 with p50 which does not possess a transactivation domain [9]. NFB is normally sequestered in the cytoplasm of non-stimulated cells and consequently must be translocated into the nucleus to function. The subcellular location of NFB is controlled by a family of inhibitory proteins called IBs [10]. One of the most important regulators of mammalian NFB is IB. When IB binds to the p50/p65 heterodimer complex, it maintains the heterodimers in the cytoplasm and prevents activation of NFB target gene transcription [10]. In response to cell stimulation, such as LPS, IB undergoes rapid phosphorylation leading to polyubiquitination and 26S proteasome-mediated degradation, allowing NFB to translocate into the nucleus and to activate target genes [10]. Our aim in this study is to examine if the inhibitory effect of 1,25(OH)2D3 and 1,24(OH)2D2 on TNF production in the macrophage cell line P388D1 is mediated through reduction of NFB activity and to find a possible mechanism for the inhibitory effect. Since current anti-inflammatory therapeutic agents, such as steroids or anti-TNF antibodies, have significant side effects, therapeutic use of the less hypercalcaemic analog, 1,24(OH)2D2, as an anti-inflammatory agent may provide a breakthrough in pharmaceutical application [2].
|
Subjects and methods |
|---|
|
TopAbstractIntroductionSubjects and methodsDiscussionReferences |
|---|
Materials
1,25(OH)2D3 was kindly provided by Hoffman La-Roche, (Basel, Switzerland) and 1,24(OH)2D2 by Bone Care International Co. (Madison, WI, USA).
Methods
Incubation of cells
P388D1 cells, a murine macrophage cell line, were treated with 1,25(OH)2D3, (10–7 M) or 1,24(OH)2D2 (10–7 M) for 16 h in RPMI medium containing 2% FCS. Then they were exposed to 1 µg/ml of LPS (E. coli 055:B5 lipopolysaccharide LPS, Sigma), for 8 h for luciferase assay, 6 h for TNF protein determination by ELISA, 2.5 h for NFB and IB-mRNA determination by reverse transcriptase-polymerase chain reaction (RT-PCR) or for 0.5 h for NFB and IB protein measurement by western blot and electrophoretic mobility shift assay (EMSA).
TNF protein determination
TNF protein levels were determined by ELISA (R&D Systems, Minneapolis, MN, USA).
Plasmid DNA purification system
We used the Wizard PureFection Plasmid DNA Purification System (Promega, Madison, WI, USA), which includes a proprietary endotoxin removal resin.
Transfection and luciferase assay
P388D1 cells were transfected by electroporation (350 V, 1500 µF, Easyject optima). With 1.5 µg of reporter plasmid pNFB-Luc (Clontech, Palo Alto, CA), 5 x 106 cells were transfected. After transfection, cells were seeded into six-well plates (250 x 103/well). After 24 h of incubation, cells were treated with 1,25(OH)2D3 (10–7 M) or 1,24(OH)2D2 (10–7 M) for 16 h and activated with LPS (1 µg/ml) for an additional 8 h. Finally, the medium of each sample was collected and assayed for TNF. Simultaneously, the cells were harvested for luciferase assay. Cells were lysed by lysis buffer (Promega) and one freeze–thaw cycle. Supernatants containing cell extracts were obtained after centrifugation for 5 min at 13 000 g and stored at –70°C. The assay to determine NFB activity was performed for each sample by injecting 100 µl of substrate solution to 20 µl of cell extract by a luminometer. Luciferase activity was normalized by total protein concentration and variations in transfection efficiency.
Cell lysate preparation
P388D1 cells were treated with 1,25(OH)2D3 or 1,24(OH)2D2 as described previously, followed by stimulation with 1 µg/ml of LPS for an additional 0.5 h. After the stimulation period, whole-cell lysate, cytoplasmatic and nuclear extracts were obtained according to the procedure described by Jiang et al. [11]. The purity of the fractions was confirmed by western blot using an anti-actin (Oncogen, Boston, MA) which is specific for the cytosolic fraction and by an anti-PCNA (BD Biosciences, USA) a specific marker for the nuclear fraction. The lysis buffer we used contained in addition to a protease inhibitor mixture (Sigma-Aldrich, Rehovot, Israel) two phosphatase inhibitors (Na3VO4 and NaF).
EMSA
Nuclear extracts from P388D1 cells were prepared as described previously. The synthetic double-stranded oligonucleotide containing the NFB binding sequence (in the HIV-LTR) was as follows: 5'-AAT TTC CCT GGA AAG TCC CCA GCG GAA AGT CCC TTG T-3' [12]. The oligonucleotide and its complementary strand were annealed and end-labelled by T4 kinase-mediated phosphorylation reaction in the presence of [
-32P] ATP. 100 000 cpm of a [-32P] end-labelled probe was incubated with 20 µg of nuclear protein extract for 30 min at room temperature in a total volume of 30 µl of reaction buffer (1 µg/µl of poly (dI-dC) (Sigma-Aldrich) 25 mM Hepes, pH 7.9, 100 mM NaCl, 333 mM urea, 10% glycerol, 0.33% NP-40, 1 mM DTT and 5 µg acetylated BSA). Competition studies were performed by incubating nuclear extracts with an excess (100-fold) unlabelled NFB oligonucleotide for 15 min at room temperature, followed by 30 min incubation in the presence of the probe. In addition, we inhibited the binding of the NFB-p65 protein by incubating the nuclear protein lysate for 60 min on ice with 1 µl of polyclonal competing antibody directed against p65 (anti-NFB p65, CT Upstate Biotechnology, Charlottesville, VA, USA). Samples were subjected to electrophoresis on a 7% non-denaturating polyacrilamide gel at 4°C for 1.5 h. The gels were dried and exposed to X-ray film. To quantitate the amount of NFB proteins specifically bound to the probe, the intensity of the bands was calculated using densitometric analysis.
Western blot
P388D1 cells were treated with 1,25(OH)2D3 or 1,24(OH)2D2 (10–7 M) for 16 h followed by an additional 0.5 h of incubation with LPS (1 µg/ml). At the end of the incubation period the cells were lysed and nucleus and cytosol fractions were prepared for the western blot procedure. The extracts were subjected to electrophoresis in SDS-PAGE 12.5% and transferred to a nitrocellulose membrane (Gellman, Italy). The primary antibodies used were the rabbit polyclonal antibodies of anti-IB (Santa Cruz, , CA, USA), and anti-NFB-p65 (UBI-Upstate Biotechnology, NY, USA), at a 1/1000 dilution. To detect the phosphorylation of Ser32 of IB, anti-phosphoserine-IB monoclonal antibody was used (mouse monoclonal antibodies anti-phospho-Ser32-IB Santa Cruz) at a 1/1000 dilution.
NFB and IB-mRNA analysis
NFB-P65-mRNA and IB-mRNA were determined by RT-PCR of total RNA extracted from P388D1 cells. Cells were incubated as described above and total RNA was extracted from the cells with the RNeasy Mini Kit (Qiagen). For RNA decay analysis, cells were treated with or without 1,25(OH)2D3 and 1,24(OH)2D2 (10–7 M). Subsequently, actinomycin-D (Sigma) was added (1 µg/ml) and the cells were incubated for various lengths of time followed by RNA extraction.
NFB and IB RT-PCR and real-time PCR
For cDNA generation, 13 µl of RNA sample was added to each 7 µl of reverse transcriptase reaction mixture, as described in [3]. cDNA was then amplified by PCR using specific primers (Table 1). To 45 µl of PCR reaction mixture (Ready Mix PCR Master Mix, ABgene, and Surrey, UK), 5 µl of reverse transcription product was added as per the protocol of the manufacturer. Thirty cycles for NFB-p65, 25 cycles for IB and 25 cycles for ß-actin were in the exponential phase of amplification in most of the experiments, thus permitting comparison of mRNA levels in different samples. On an agarose gel, 8 µl of each sample containing amplified cDNA were loaded as previously described [3]. NFB-p65 and IB levels were normalized according to ß-actin levels in order to compensate for differences in mRNA between the various samples.
|
Quantitative real-time PCR assays were carried out for NF
B-p65, IB and ß-actin. Templates (7 µl) were diluted 5-fold and then mixed with primers (0.2 mM) and Thermo-Start master mix (ABgene). SYBR green I dye (Amresco, Inc. USA) was added to the reaction mixture. Reactions were carried out in the Rotor-Gene Real-Time Analysis Software PCR machine (Corbett-Research). Standard cycling conditions for this instrument were used: 15 min initial denaturation at 95°C, then 40 cycles denaturation at 95°C for 15 or 20 s; annealing (the exact temperature was determined according to the primers) for 15 or 20 sec; extension at 72°C for 20 s. A melting curve was then sketched to ensure the purity of the amplified product. The efficiency of the real-time PCR reactions was between 0.95 and 1.01.
Statistical analysis
Results are presented as mean±standard error of the mean (SE). ANOVA was used to compare TNF, NFB and IB levels between treatments. P-values below 0.05 were considered significant.
Results
1,25(OH)2D3 and 1,24(OH)2D2 decrease TNF protein levels.
TNF protein levels were examined in P388D1 cells media using a specific ELISA. Pre-incubation of P388D1 cells for 16 h with increasing concentrations (10–10–10–7 M) of 1,25(OH)2D3 or 1,24(OH)2D2 (not all concentrations are shown), followed by stimulation with LPS (1 µg/ml) for an additional 6 h, induced a statistically significant dose-related decrement in TNF protein concentrations (Figure 1). TNF secretion was downregulated significantly (29% inhibition, P<0.01) in the presence of a physiological concentration (10–10 M) of 1,25(OH)2D3 and reached a maximal effect (61% inhibition, P<0.001) with higher concentration of 10–8 M (data not shown) or 10–7 M of 1,25(OH)2D3/1,24(OH)2D2.
|
1,25(OH)2D3 and 1,24(OH)2D2 inhibit NF
B activity.To examine the effect of 1,25(OH)2D3 and 1,24(OH)2D2 on transcriptional activity of NF
B, we transiently transfected P388D1 cells with the pNFB-Luc construct. pNFB-Luc contains a firefly luciferase gene that is especially designed for monitoring the activation of the NFB signal transduction pathway. Analysis of luciferase activity in cell extracts from transfected cells confirmed that stimulation of the cells with LPS results in an increase in NFB-driven luciferase expression (Figure 2). In the presence of 1,25(OH)2D3 or 1,24(OH)2D2, however, the increase in luciferase activity was partially inhibited (Figure 2). Similar results were obtained in separate experiments. We also found a positive correlation between inhibition of NFB activity and decrement in TNF protein levels induced by 1,25(OH)2D3 and 1,24(OH)2D2, as described previously (Figure 1).
|
The inhibitory effect of 1,25(OH)2D3 and 1,24(OH)2D2 on NF
B activity, as shown by luciferase analysis (Figure 2), was in accordance with the results obtained from EMSA (Figure 3). Nuclear extracts of P388D1 cells were incubated with end-labelled double stranded oligonucleotide possessing the NFB consensus site. The nuclear extracts from the LPS-stimulated P388D1 cells yielded a large band in comparison to the unstimulated cells, and exhibited DNA binding activity to the NFB site containing oligonucleotide (Figure 3). However, the nuclear extracts of P388D1 cells treated with 1,25(OH)2D3 or 1,24(OH)2D2 caused a marked reduction in DNA-protein complex binding activity, as evidenced by a decrease in the intensity of this band.
|
A competing antibody directed against the NF
B subunit p65 blocked the binding of the nuclear extracts to the labelled oligonucleotide indicating the specificity of this assay. However, when cells were treated with an isotype-matched control antibody, the DNA-protein complex was not affected. The labelled oligonucleotide could be competed out by 100-fold excess of specific unlabelled ‘cold’ DNA probe.
Decrease in NFB-p65 protein levels in the nuclear compartment by 1,25(OH)2D3 and 1,24(OH)2D2 is associated with induced expression in the cytosol
After demonstrating that 1,25(OH)2D3 and 1,24(OH)2D2 inhibit NFB activity as measured by luciferase assay (Figure 2) and EMSA (Figure 3), we tried to elucidate the mechanism responsible for this down-regulation. We found that stimulation of the cells with LPS induced an increase in NFB-p65 protein expression in the nucleus, while in the cytosol it decreased NFB-p65 protein expression (Figure 4). On the other hand, treatment of P388D1 cells with 1,25(OH)2D3 or 1,24(OH)2D2 (with or without stimulation with LPS) decreased NFB-p65 levels in the nucleus (Figure 4) and increased NFB-p65 levels in the cytosol (Figure 4). NFB-p65 levels in total lysate were not affected by 1,25(OH)2D3 and 1,24(OH)2D2 (Figure 4). Decreased NFB-p65 translocation to the nuclear compartment, resulting from treatment with 1,25(OH)2D3 or 1,24(OH)2D2 was associated with increased levels of NFB-p65 in the cytosol (Figure 4). Treatment of cells with 1,25(OH)2D3 or 1,24(OH)2D2 without LPS caused a similar effect in NFB-p65 expression or localization, in comparison to LPS-unstimulated cells (Figure 4).
|
1,25(OH)2D3 and 1,24(OH)2D2 do not affect NF
B-p65 mRNA levels.To support the finding that NF
B-p65 protein levels did not change in the total lysate, when treated by 1,25(OH)2D3 and 1,24(OH)2D2 (Figure 4), we measured NFB-p65 mRNA levels by using specific primers (Table 1). RT-real-time PCR and RT-PCR of total RNA from P388D1 cells yielded a band of mRNA for NFB-p65 at the expected size of 602 bp (Figure 5). 1,25(OH)2D3 and 1,24(OH)2D2 had no effect on NFB-p65 mRNA levels.
|
1,25(OH)2D3 and 1,24(OH)2D2 increase I
B protein levels.Since we found no effect on total NF
B-p65 protein (Figure 4) and NFB-p65 mRNA levels (Figure 5) in P388D1 cells treated with 1,25(OH)2D3 or 1,24(OH)2D2 we decided to investigate if the decrease in NFB activity is associated with its inhibitor IB. We found that stimulation of P388D1 cells with LPS decreased IB protein levels in the cytosol, whereas 1,25(OH)2D3 and 1,24(OH)2D2 significantly increased IB protein levels (x4.5) (Figure 6).
|
1,25(OH)2D3 and 1,24(OH)2D2 increase I
B-mRNA levels.To determine whether the induction of I
B protein levels results from an increase in mRNA production, we analysed the effect of 1,25(OH)2D3 and 1,24(OH)2D2 on expression of IB-mRNA in P388D1 cells. RT-real-time PCR and RT-PCR were performed for IB-mRNA by using specific primers. As expected, the band for IB appeared at 469 bp (Figure 7). The densitometric evaluation expressed in Figure 7 indicates that IB-mRNA was significantly induced by 1,25(OH)2D3 and 1,24(OH)2D2. From Figure 7 we can speculate that one of the reasons for the increased expression of IB protein by 1,25(OH)2D3 and 1,24(OH)2D2 (Figure 6) is up-regulation of IB-mRNA levels.
|
1,25(OH)2D3 and 1,24(OH)2D2 increase I
B-mRNA stability.The effect of 1,25(OH)2D3 and 1,24(OH)2D2 on I
B-mRNA stability was examined by a real-time PCR technique, using actinomycin D, an inhibitor of DNA-depended RNA synthesis. Figure 8 shows that 1,25(OH)2D3 and 1,24(OH)2D2 inhibit IB-mRNA degradation. The half-life of IB-mRNA increased from 110 to 190 min in the presence of 1,25(OH)2D3 or 1,24(OH)2D2, indicating that IB-mRNA is more stable in P388D1 cells treated with 1,25(OH)2D3 or 1,24(OH)2D2 than in untreated cells (Figure 8A, B).
|
1,25(OH)2D3 and 1,24(OH)2D2 decrease I
B phosphorylation.1,25(OH)2D3 and 1,24(OH)2D2 augment the cellular content of I
B protein (Figure 6) through an accumulation of IB-mRNA (Figure 7). Figure 8 shows that the induction of IB-mRNA caused by 1,25(OH)2D3 and 1,24(OH)2D2 results from increased IB-mRNA stability (Figure 8).
Numerous studies have reported a requirement for phosphorylation of IB on serine residues to target IB for ubiquitination and degradation. Therefore, another possible reason for the increase in IB protein levels by 1,25(OH)2D3 and 1,24(OH)2D2 may be inhibition of IB protein degradation. We next asked whether vitamin D affects the activity of IB Kinase (IKK). IKK phosphorylates IB and targets its protein for ubiquitination and degradation by the 26S proteasome. The effect of vitamin D on the activity of IKK was examined by measuring the levels of phospho-IB at serine residues by western blot analysis, using an anti-phospho-IB antibody. Figure 9 shows that stimulation with LPS caused a slight increase in phosphorylation of IB protein while 1,25(OH)2D3 and 1,24(OH)2D2 induced a decrease in IB phosphorylation (Figure 9). Since phospho-IB levels are dependent on IKK-complex activity and on total IB levels, the values of phospho-IB were calculated for each treatment by the ratios of phospho-IB/total IB in order to compensate for differences in the amount of phospho-IB caused by its degradation (Figure 9).
|
|
Discussion |
|---|
|
TopAbstractIntroductionSubjects and methodsDiscussionReferences |
|---|
Similar to our findings from a previous investigation, [3,4], in our present study we showed that overnight incubation of peritoneal macrophages (16 h) with 1,25(OH)2D3 or 1,24(OH)2D2 significantly inhibited the secretion of TNF
in the murine macrophage cell line P388D1 in a dose-dependent manner. Given the methods we used in our experiments, activities such as cultivating large amounts of cells for western blot analysis or performing a transfection assay, were difficult to perform with human macrophages, and we were obliged to use a cell line. Since our findings showed that vitamin D had the same inhibitory effect on TNF-mRNA and proteins levels in both peritoneal macrophages and P388D1 cells, we decided to use the P388D1 cells for our experiments. Following exposure to physiological levels of vitamin D (10–10 M), TNF secretion was inhibited by 29%, this inhibition strengthening to as much as 61% at 10–7 M. Since peritoneal macrophages are able to metabolize 25-OH-D3 to its active metabolite 1,25(OH)2D3 [1], it is possible that in the microenvironment of the peritoneum the active concentrations of 1,25(OH)2D3 are higher than serum levels causing the inhibitory effect of vitamin D to be more profound.
The present study was aimed at exploring the mechanism underlying the inhibitory effect on TNF and determining whether this effect is mediated by the activity of its major transcription factor, NFB. We illustrated the inhibitory effect of 1,25(OH)2D3 and 1,24(OH)2D2 on LPS-induced NFB activity by EMSA and by a promoter activity assay using luciferase as a reporter gene. Both assays clearly indicated that nuclei of vitamin D-treated cells stimulated with LPS contain less NFB DNA-binding activity than untreated cells. We then tested whether the reduced LPS-induced NFB activity was the result of a decrease in NFB cellular content or of a rise in the cytosolic levels of its inhibitor IB. We found that vitamin D had no effect on total protein or mRNA levels of NFB-p65 but did increase cytoplasmic NFB-p65 levels and decreased NFB-p65 levels in the nuclear portion of this transcription factor.
Inhibition of TNF required a long incubation period with vitamin D suggesting that the inhibitory mechanism involves a synthesis or degradation of protein(s). Indeed the levels of IB which is responsible for retention of NFB in the cytoplasm were upregulated in treated cells. 1,25(OH)2D3 and 1,24(OH)2D2 induced an increase of 6.5-fold in the levels of IB-mRNA and 4.5-fold in its protein levels. To elucidate the mechanism of IB upregulation, we tested whether the increase in IB levels is caused by changes in IB-mRNA stability and/or IB protein phosphorylation levels. IB-mRNA was found to be more stable in P388D1 cells treated with 1,25(OH)2D3 or 1,24(OH)2D2 (IB-mRNA half-life was prolonged from 110 to 190 min), indicating that these agents impede IB-mRNA degradation. We also found that vitamin D markedly reduced the basal and LPS-induced phosphorylation of IB. Since phosphorylation is the first step in marking IB for ubiquitination, the decrease in IB phosphorylation probably reduces its degradation. Hence, we can conclude that 1,25(OH)2D3 and 1,24(OH)2D2 upregulate IB levels through a dual mechanism, namely stabilization of mRNA and reduction of phosphorylation.
The main significance of our present investigation is that we succeeded in revealing a possible mechanism for the inhibition of TNF by 1,25(OH)2D3 and 1,24(OH)2D2 in macrophages. This mechanism is mediated through NFB, the major transcription factor of TNF. NFB regulates both the production of TNF by mononuclear cells stimulated by LPS and the response of cells targeted by TNF. To the best of our knowledge, this is the first time that the anti-inflammatory mechanism activity of the less calcaemic analog 1,24(OH)2D2 has been reported in the literature and raises its potentialities as an effective drug in combating inflammatory diseases.
Similar to our findings, other studies have shown that 1,25(OH)2D3 suppresses NFB activity in a variety of cells. In melanoma cells, suppressed NFB activity was associated with inhibition of IL-8 production [13], and in monocytic cells with decreased production of IL-12 and mRNA expression of IL-12 p35 and p40 subunits [14] and decreased production of chemokines by pancreatic islets [15]. In T-lymphocytes and peripheral blood mononuclear cells, the suppressive effect of 1,25(OH)2D3 on NFB activity was associated with reduced cellular content of NFB proteins. The suppressive effect of vitamin D on NFB, therefore, would appear to be a general effect that occurs in various cell types and affects various inflammatory and immune processes. Furthermore, 1,25(OH)2D3 was demonstrated to suppress another transcription factor, NFATp/AP-1 which is involved in the biological activities of cytokines. 1,25(OH)2D3 represses IL-2 gene by a direct inhibition of VDR-dependent NFATp/AP-1 complex formation [16].
Similar to the effect of vitamin D, corticosteroids also decrease NFB activity, at least partly, by up-regulating IB levels [17, 18]. In previous studies, we and others have shown that 1,25(OH)2D3 stimulates the killing capacity of macrophages, an effect mediated by an enhanced production of superoxide [19]. Other studies have also found that immunosuppression is caused by downregulation of the pro-inflammatory cytokine effector-TNF by 1,25(OH)2D3. This diversity of anti-inflammatory effects of 1,25(OH)2D3 shows it to be an important immune response regulator at inflammatory sites. Recent reports on the successful use of 1,25(OH)2D3 as an anti-inflammatory agent in transplantations strengthen this hypothesis [20].
Although the present results suggest the therapeutic possibilities of 1,25(OH)2D3 as an anti-inflammatory agent, its clinical use is restricted because of its hypercalcaemic activity [2]. In previous in vitro studies we demonstrated the anti-inflammatory activity of vitamin D2 analog, 1,24(OH)2D2 and found it to be equipotential to that of 1,25(OH)2D3 [3, 4]. The present study confirmed that both agents are equipotential and share the same mechanism of NFB inhibition. Since 1,24(OH)2D2 has a less calcaemic effect than 1,25(OH)2D3, its use as an anti-inflammatory agent may have clinical significance and deserves further investigation in order to validate our findings.
In conclusion, this study has demonstrated that 1,25(OH)2D3 and 1,24(OH)2D2 trigger the rise in IB protein and mRNA levels, as a result of stabilizing IB-mRNA and reducing IB phosphorylation. Elevated IB levels following overnight vitamin D treatment reduce the response to LPS by diminishing the amount of NFB translocated to the nucleus. Since NFB is needed for effective transcription of inflammatory genes, its reduced levels following vitamin D treatment is probably the cause of the inhibition of inflammatory genes such as TNF.
|
Acknowledgments |
|---|
This study was supported by a research grant provided by the Ministry of Health, Israel and by the ‘Dr Montague Robin Fleisher Kidney Transplant Unit Fund’.
Conflict of interest statement. None declared.
|
References |
|---|
|
TopAbstractIntroductionSubjects and methodsDiscussionReferences |
|---|
- Shany S, Rapoport J, Zuili I, Gavriel A, Lavi N, Chaimovitz C. Metabolism of 25-OH-vitamin D3 by peritoneal macrophages from CAPD patients. Kidney Int 1991; 39: 1005–1011[Medline]
- May E, Asadullah K, Zugel U. Immunoregulation through 1,25-dihydroxyvitamin D3 and its analogs. Curr Drug Targets Inflamm Allergy 2004; 3: 377–393[CrossRef][Medline]
- Lahav-Cohen M, Douvdevani A, Chaimovitz C, Shany S. Regulation of TNF-alpha by 1alpha,25-dihydroxyvitamin D3 in human macrophages from CAPD patients. Kidney Int 2001; 59: 69–75[CrossRef][Medline]
- Shany S, Levy Y, Lahav-Cohen M. The effects of 1alpha, 24(S)-dihydroxyvitamin D(2) analog on cancer cell proliferation and cytokine expression. Steroids 2001; 66: 319–325[CrossRef][Medline]
- Schottelius AJ, Moldawer LL, Dinarello CA, Asadullah K, Sterry W, Edwards CK,3rd. Biology of tumor necrosis factor-alpha-implications for psoriasis. Exp Dermatol 2004; 13: 193–222[CrossRef][ISI][Medline]
- Udalova IA, Knight JC, Vidal V, Nedospasov SA, Kwiatkowski D. Complex NF-kappaB interactions at the distal tumor necrosis factor promoter region in human monocytes. J Biol Chem 1998; 273: 21178–21186
[Abstract/Free Full Text] - Yao J, Mackman N, Edgington TS, Fan ST. Lipopolysaccharide induction of the tumor necrosis factor-alpha promoter in human monocytic cells. Regulation by Egr-1, c-Jun, and NF-kappaB transcription factors. J Biol Chem 1997; 272: 17795–17801
[Abstract/Free Full Text] - Liu H, Sidiropoulos P, Song G et al. TNF-alpha gene expression in macrophages: regulation by NF-kappa B is independent of c-Jun or C/EBP beta. J Immunol 2000; 164: 4277–4285
[Abstract/Free Full Text] - Urban MB, Schreck R, Baeuerle PA. NF-kappa B contacts DNA by a heterodimer of the p50 and p65 subunit. Embo J 1991; 10: 1817–1825[ISI][Medline]
- Hayden MS, Ghosh S. Signaling to NF-kappaB. Genes Dev 2004; 18: 2195–2224
[Abstract/Free Full Text] - Jiang Y, Chen D, Lyu SC, Ling X, Krensky AM, Clayberger C. DQ 65–79, a peptide derived from HLA class II, induces I kappa B expression. J Immunol 2002; 168: 3323–3328
[Abstract/Free Full Text] - Jain RG, Phelps KD, Pekala PH. Tumor necrosis factor-alpha initiated signal transduction in 3T3-L1 adipocytes. J Cell Physiol 1999; 179: 58–66[CrossRef][ISI][Medline]
- Harant H, Andrew PJ, Reddy GS, Foglar E, Lindley IJ. 1alpha,25-dihydroxyvitamin D3 and a variety of its natural metabolites transcriptionally repress nuclear-factor-kappaB-mediated interleukin-8 gene expression. Eur J Biochem 1997; 250: 63–71[ISI][Medline]
- D’Ambrosio D, Cippitelli M, Cocciolo MG et al. Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J Clin Invest 1998; 101: 252–262[ISI][Medline]
- Giarratana N, Penna G, Amuchastegui S, Mariani R, Daniel KC, Adorini L. A vitamin D analog down-regulates proinflammatory chemokine production by pancreatic islets inhibiting T cell recruitment and type 1 diabetes development. J Immunol 2004; 173: 2280–2287
[Abstract/Free Full Text] - Alroy I, Towers TL, Freedman LP. Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol Cell Biol 1995; 15: 5789–5799[Abstract]
- Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS,Jr. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 1995; 270: 283–286
[Abstract/Free Full Text] - Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 1995; 270: 286–290
[Abstract/Free Full Text] - Deutsch A, Chaimovitzch C, Nagauker-Shriker O, Zlotnik M, Shany S, Levy R. Elevated superoxide generation in mononuclear phagocytes by treatment with 1 alpha hydroxyvitamin D3: changes in kinetics and in oxidase cytosolic factor p47. J Am Soc Nephrol 1995; 6: 102–109[Abstract]
- Briffa NK, Keogh AM, Sambrook PN, Eisman JA. Reduction of immunosuppressant therapy requirement in heart transplantation by calcitriol. Transplantation 2003; 75: 2133–2134[CrossRef][Medline]
Accepted in revised form: 13.10.05
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Y. Talmor, E. Golan, S. Benchetrit, J. Bernheim, O. Klein, J. Green, and G. Rashid Calcitriol blunts the deleterious impact of advanced glycation end products on endothelial cells Am J Physiol Renal Physiol, May 1, 2008; 294(5): F1059 - F1064. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Wu-Wong, M. Nakane, J. Ma, X. Ruan, and P. E. Kroeger Elevated phosphorus modulates vitamin D receptor-mediated gene expression in human vascular smooth muscle cells Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1592 - F1604. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Chen, G. P. Sims, X. X. Chen, Y. Y. Gu, S. Chen, and P. E. Lipsky Modulatory Effects of 1,25-Dihydroxyvitamin D3 on Human B Cell Differentiation J. Immunol., August 1, 2007; 179(3): 1634 - 1647. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||